439 403 руб.
439 403 руб.
— For the treatment of patients with SEGA associated with tuberous sclerosis Complex (TSC) who require therapeutic intervention but are not candidates for curative surgical resection.The effectiveness of Afinitor ® is based on an analysis of change in SEGA volume. Clinical benefit such as improvement in disease-related symptoms or increase in overall survival has not been demonstrated.- Treatment of progressive neuroendocrine tumors of pancreatic origin (PNET) in patients with unresectable, locally advanced or metastatic disease.The safety and effectiveness of Afinitor ® in the treatment of patients with carcinoid tumors have not been established.- For the treatment of hormone receptor – positive, HER2/neu negative advanced breast cancer, in combination with exemestane, in postmenopausal women without symptomatic visceral disease after recurrence or progression follwing a non – steroidal aromatase inhibitor.- Afinitor ® is indicated for the treatment of adult patients with renal angiomyolipoma and tuberous sclerosis complex (TSC), not requiring immediate surgery. The effectiveness of Afinitor ® in treatment of renal angiomyolipoma is based on an analysis of durable objective responses in patients treated for a median of 8.3 months. Further follow-up of patients is required to determine long-term outcomes.- Afinitor ® is indicated for the treatment of patients with advanced renal cell carcinoma, whose disease has progressed on or after treatment with VEGF-targeted therapy.
|В Израиле||В России|
|AFINITOR 10 MG,CERTICAN 0.75 MG TABLETS,CERTICAN 0.25 MG TABLETS,AFINITOR 5 MG,CERTICAN 0.5 MG TABLETS,AFINITOR 2.5 MG||Афинитор
Профилактика отторжения трансплантата у взрослых реципиентов трансплантата почки и сердца с низким и средним иммунологическим риском, получающих базовую иммуносупрессивную терапию циклоспорином (в виде микроэмульсии) и ГКС.
|Количество в упаковке||
30 X TABLETS
© ИСАПТЕКА.РУ 2018